HIGHLIGHTS
- who: APOBEC family et al. from the Shenyang Pharmaceutical University, China have published the research work: Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma, in the Journal: (JOURNAL)
- what: The analysis shows that there is also a strong PPI between CUL5 and APOBEC1/3A/3H, study is the first bioinformatics analysis of the function of APOBEC1/ 3A/3G/3H in PAAD.
- how: In this study R (version 3.6.3) was used to analyze the expression level of APOBEC1/3A/3G . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.